Multi-omics uncovers immune-modulatory molecules in plasma contributing to resistance exercise-ameliorated locomotor disability after incomplete spinal cord injury
The study was retrospectively registered on 17 July, 2024, in Chinese Clinical Trial Registry (No.: ChiCTR2400087038) at https://www.chictr.org.cn/ .
Authors
- Jiajia Yao
- Tong Yin
- Chuijin Wei
- Xiaoqin Ding
- Luwen Zhu (ORCID: https://orcid.org/0000-0003-4638-7004)
- Zengqiang Ouyang
- Jibao Chen (ORCID: https://orcid.org/0000-0002-4656-822X)
- Liaoliao Dong
- Feng Ye (ORCID: https://orcid.org/0000-0002-4983-8520)
- Jing Qiao (ORCID: https://orcid.org/0000-0002-1263-986X)
- Haiqing Li (ORCID: https://orcid.org/0000-0003-0329-8933)
- Lin Cheng (ORCID: https://orcid.org/0000-0002-3688-9863)
- Ping Yu (ORCID: https://orcid.org/0009-0004-3268-5187)
- Shu-Min Xiong (ORCID: https://orcid.org/0009-0007-8735-4539)
- Yunhan Tang
- Ren Zhou
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Shanghai Sunshine Rehabilitation Center (CN)
- Shanghai Institute of Hematology (CN)
Publication Details
- Journal
- Genome Medicine
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1186/s13073-025-01434-8
- Citations
- 6
- Primary Topic
- Spinal Cord Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 8.83
Funders
- Shanghai Municipal Health Commission
- Shanghai Municipal Education Commission
- Shanghai Jiao Tong University
- Shanghai Hospital Development Center
- School of Medicine, Shanghai Jiao Tong University